Cargando…

Decreased Risk of Parkinson’s Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls

BACKGROUND: Rheumatoid arthritis (RA) and the genetic risk landscape of autoimmune disorders and Parkinson’s disease (PD) overlap. Additionally, anti-inflammatory medications used to treat RA might influence PD risk. OBJECTIVE: To use a population-based approach to determine if there is an associati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bacelis, Jonas, Compagno, Michele, George, Sonia, Pospisilik, J. Andrew, Brundin, Patrik, Naluai, Åsa Torinsson, Brundin, Lena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150472/ https://www.ncbi.nlm.nih.gov/pubmed/33682730 http://dx.doi.org/10.3233/JPD-202418

Ejemplares similares

A family-based genome-wide association study of chronic rhinosinusitis with nasal polyps implicates several genes in the disease pathogenesis
por: Bohman, Anton, et al.
Publicado: (2017)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?
por: Thirtamara-Rajamani, Keerthi, et al.
Publicado: (2017)

Parkinson’s Disease: We Care!
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson’s disease etiology
por: Coetzee, Simon G., et al.
Publicado: (2016)

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease
por: Li, Peipei, et al.
Publicado: (2021)

What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
por: Dunning, Christopher J.R., et al.
Publicado: (2013)

The Times They Are a-Changin’: Parkinson’s Disease 20 Years from Now
por: Brundin, Patrik, et al.
Publicado: (2018)

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
por: Xie, Aoji, et al.
Publicado: (2022)

Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
por: Sardi, S. Pablo, et al.
Publicado: (2018)

Is COVID-19 a Perfect Storm for Parkinson’s Disease?
por: Brundin, Patrik, et al.
Publicado: (2020)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

A novel automated morphological analysis of Iba1+ microglia using a deep learning assisted model
por: Stetzik, Lucas, et al.
Publicado: (2022)

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
por: Stott, Simon R. W., et al.
Publicado: (2021)

A Possible Mechanism behind Autoimmune Disorders Discovered By Genome-Wide Linkage and Association Analysis in Celiac Disease
por: Östensson, Malin, et al.
Publicado: (2013)

Introduction
por: Patrik, Brundin
Publicado: (2017)

Intestinal gluconeogenesis is downregulated in pediatric patients with celiac disease
por: Karlson, Olof, et al.
Publicado: (2022)

Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
por: George, Sonia, et al.
Publicado: (2019)

Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
por: von Linstow, Christian U., et al.
Publicado: (2020)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease
por: Kulkarni, Aishwarya S, et al.
Publicado: (2022)

Exendin-4 Treatment Improves LPS-Induced Depressive-Like Behavior Without Affecting Pro-Inflammatory Cytokines
por: Ventorp, Filip, et al.
Publicado: (2017)

The Association of HLA Alleles and Haplotypes with Age of Disease Onset in Pakistani Psoriatic Patients
por: Munir, Saeeda, et al.
Publicado: (2023)

Astrocyte Responses to Complement Peptide C3a are Highly Context-Dependent
por: Pekna, Marcela, et al.
Publicado: (2022)

Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models
por: Burbulla, Lena F., et al.
Publicado: (2021)

Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis
por: Widner, Håkan, et al.
Publicado: (1988)

Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?
por: Barker, Roger A., et al.
Publicado: (2016)

Single Nucleotide Polymorphisms in the FADS Gene Cluster but not the ELOVL2 Gene are Associated with Serum Polyunsaturated Fatty Acid Composition and Development of Allergy (in a Swedish Birth Cohort)
por: Barman, Malin, et al.
Publicado: (2015)

The associations between ADHD, pain, inflammation, and quality of life in children and adolescents—a clinical study protocol
por: Kerekes, Nóra, et al.
Publicado: (2022)

Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis
por: Paakinaho, Anne, et al.
Publicado: (2022)

Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
por: Gil, Joana MAC, et al.
Publicado: (2004)

Dental Scaling Decreases the Risk of Parkinson’s Disease: A Nationwide Population-Based Nested Case-Control Study
por: Chen, Chang-Kai, et al.
Publicado: (2018)

Parkinson Matters
por: Darweesh, Sirwan K.L., et al.
Publicado: (2018)

Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
por: Jellen, Leslie C., et al.
Publicado: (2021)

Genes involved in muscle contractility and nutrient signaling pathways within celiac disease risk loci show differential mRNA expression
por: Montén, Caroline, et al.
Publicado: (2015)

T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
por: George, Sonia, et al.
Publicado: (2021)

Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson’s Disease?
por: von Linstow, Christian U., et al.
Publicado: (2020)

Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum
por: Lindqvist, Daniel, et al.
Publicado: (2012)

Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
por: Lema Tomé, Carla M., et al.
Publicado: (2012)

Altered peripheral amino acid profile indicate a systemic impact of active celiac disease and a possible role of amino acids in disease pathogenesis
por: Torinsson Naluai, Åsa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_njpp6ot0ta98kviga80d046t7m